Skip to main content
Top
Published in: Endocrine 2/2014

01-06-2014 | Fellows Corner

“Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging

Authors: Rosa Maria Paragliola, Francesco Torino, Paola Senes, Laura Castellino, Vanda Salutari, Alfredo Pontecorvi, Giovanni Scambia, Salvatore M. Corsello

Published in: Endocrine | Issue 2/2014

Login to get access

Abstract

Hyperandrogenism is a common finding in premenopausal age and is generally caused by polycystic ovarian syndrome or other benign disease. Androgen-secreting tumors represent only 0.2 % of the causes of hyperandrogenism and usually present with severe clinical features, abrupt onset, and very high androgens levels. We describe here three cases of occult ovarian Leydig cell tumors suspected on the basis of severe clinical features of hyperandrogenism rapidly worsening, with elevated serum total testosterone levels, in which bilateral ovariectomy was performed and tumor was confirmed by post-operative histology. In all three cases, imaging was negative for ovarian tumor. Moreover, in one case the confounding concomitant finding of bilateral adrenal masses posed an additional challenge. Our experience highlights that testosterone levels represent the most helpful marker in the diagnosis of androgen-secreting ovarian tumor. In the absence of imaging findings, bilateral ovariectomy should be indicated, if supported by unequivocal clinical and laboratory data.
Literature
1.
go back to reference R. Azziz, L.A. Sanchez, E.S. Knochenhauer, C. Moran, J. Lazenby, K.C. Stephens, K. Taylor, L.R. Boots, Androgen excess in women: experience with over 1000 consecutive patients. J. Clin. Endocrinol. Metab. 89, 453–462 (2004)PubMedCrossRef R. Azziz, L.A. Sanchez, E.S. Knochenhauer, C. Moran, J. Lazenby, K.C. Stephens, K. Taylor, L.R. Boots, Androgen excess in women: experience with over 1000 consecutive patients. J. Clin. Endocrinol. Metab. 89, 453–462 (2004)PubMedCrossRef
3.
go back to reference A.K. Shanbhogue, D.K. Shanbhogue, S.R. Prasad, V.R. Surabhi, N. Fasih, C.O. Menias, Clinical syndromes associated with ovarian neoplasms: a comprehensive review. Radiographics 30, 903–919 (2010)PubMedCrossRef A.K. Shanbhogue, D.K. Shanbhogue, S.R. Prasad, V.R. Surabhi, N. Fasih, C.O. Menias, Clinical syndromes associated with ovarian neoplasms: a comprehensive review. Radiographics 30, 903–919 (2010)PubMedCrossRef
4.
go back to reference U. Blume-Peytavi, S. Atkin, J. Shapiro, S. Lavery, R. Grimalt, R. Hoffmann, U. Gieler, A. Messenger, European Consensus on the evaluation of women presenting with excessive hair growth. Eur. J. Dermatol. 19, 597–602 (2009)PubMed U. Blume-Peytavi, S. Atkin, J. Shapiro, S. Lavery, R. Grimalt, R. Hoffmann, U. Gieler, A. Messenger, European Consensus on the evaluation of women presenting with excessive hair growth. Eur. J. Dermatol. 19, 597–602 (2009)PubMed
5.
go back to reference E. Carmina, F. Rosato, A. Jannì, M. Rizzo, R.A. Longo, Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J. Clin. Endocrinol. Metab. 91, 2–6 (2006)PubMedCrossRef E. Carmina, F. Rosato, A. Jannì, M. Rizzo, R.A. Longo, Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J. Clin. Endocrinol. Metab. 91, 2–6 (2006)PubMedCrossRef
6.
go back to reference E.D. Levens, B.W. Whitcomb, J.M. Csokmay, L.K. Nieman, Selective venous sampling for androgen-producing ovarian pathology. Clin. Endocrinol. (Oxf). 70, 606–614 (2009)PubMedCentralPubMedCrossRef E.D. Levens, B.W. Whitcomb, J.M. Csokmay, L.K. Nieman, Selective venous sampling for androgen-producing ovarian pathology. Clin. Endocrinol. (Oxf). 70, 606–614 (2009)PubMedCentralPubMedCrossRef
7.
go back to reference M.S. Rothman, M.E. Wierman, How should postmenopausal androgen excess be evaluated? Clin. Endocrinol. (Oxf). 75, 160–164 (2011)PubMedCrossRef M.S. Rothman, M.E. Wierman, How should postmenopausal androgen excess be evaluated? Clin. Endocrinol. (Oxf). 75, 160–164 (2011)PubMedCrossRef
8.
go back to reference W. Rosner, H. Vesper, Toward excellence in testosterone testing: a consensus statement. J. Clin. Endocrinol. Metab. 95, 4542–4548 (2010)PubMedCrossRef W. Rosner, H. Vesper, Toward excellence in testosterone testing: a consensus statement. J. Clin. Endocrinol. Metab. 95, 4542–4548 (2010)PubMedCrossRef
9.
go back to reference Practice Committee of the American Society for Reproductive Medicine, The evaluation and treatment of androgen excess. Fertil. Steril. 86, S241–S247 (2006) Practice Committee of the American Society for Reproductive Medicine, The evaluation and treatment of androgen excess. Fertil. Steril. 86, S241–S247 (2006)
10.
go back to reference M. Hofland, S. Cosyns, P. De Sutter, C. Bourgain, B. Velkeniers, Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases. Gynecol. Endocrinol. 29, 213–215 (2013)PubMedCrossRef M. Hofland, S. Cosyns, P. De Sutter, C. Bourgain, B. Velkeniers, Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases. Gynecol. Endocrinol. 29, 213–215 (2013)PubMedCrossRef
11.
go back to reference F.A. Tavassoli, P. Devillee, Pathology and genetics, tumours of the breast and female genital organs (World Health Organization classification of tumours, Lyon, 2003) F.A. Tavassoli, P. Devillee, Pathology and genetics, tumours of the breast and female genital organs (World Health Organization classification of tumours, Lyon, 2003)
12.
go back to reference G. Baiocchi, N. Manci, G. Angeletti, R. Celleno, D. Fratini, G. Gilardi, Pure Leydig cell tumor (hilus cell) of the ovary: a rare cause of virilization after menopause. Gynecol. Obstet. Invest. 44, 141–144 (1997)PubMedCrossRef G. Baiocchi, N. Manci, G. Angeletti, R. Celleno, D. Fratini, G. Gilardi, Pure Leydig cell tumor (hilus cell) of the ovary: a rare cause of virilization after menopause. Gynecol. Obstet. Invest. 44, 141–144 (1997)PubMedCrossRef
13.
go back to reference A. Monteagudo, D. Heller, N. Husami, R.U. Levine, R. McCaffrey, I.E. Timor-Tritsch, Ovarian steroid cell tumors: sonographic characteristics. Ultrasound Obstet. Gynecol. 10, 282–288 (1997)PubMedCrossRef A. Monteagudo, D. Heller, N. Husami, R.U. Levine, R. McCaffrey, I.E. Timor-Tritsch, Ovarian steroid cell tumors: sonographic characteristics. Ultrasound Obstet. Gynecol. 10, 282–288 (1997)PubMedCrossRef
14.
go back to reference R.K. Klotz, E. Müller-Holzner, S. Fessler, D.U. Reimer, I. Zervomanolakis, B. Seeber, V. Mattle, L. Wildt, Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration—case report and review of the literature. Exp. Clin. Endocrinol. Diabetes 118, 291–297 (2010)PubMedCrossRef R.K. Klotz, E. Müller-Holzner, S. Fessler, D.U. Reimer, I. Zervomanolakis, B. Seeber, V. Mattle, L. Wildt, Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration—case report and review of the literature. Exp. Clin. Endocrinol. Diabetes 118, 291–297 (2010)PubMedCrossRef
15.
go back to reference K. Sakamoto, R. Fujimitsu, M. Ida, S. Horiuchi, Y. Hamada, K. Yoshimitsu, MR diagnosis of steroid cell tumor of the ovary: value of chemical shift imaging. Magn. Reson. Med. Sci. 8, 193–195 (2009)PubMedCrossRef K. Sakamoto, R. Fujimitsu, M. Ida, S. Horiuchi, Y. Hamada, K. Yoshimitsu, MR diagnosis of steroid cell tumor of the ovary: value of chemical shift imaging. Magn. Reson. Med. Sci. 8, 193–195 (2009)PubMedCrossRef
16.
go back to reference R.D. Dickerson, M.J. Putman, M.E. Black, K.R. Pinto, N.G. Diamond, S. Marynick, A.B. Pinto, Selective ovarian vein sampling to localize a Leydig cell tumor. Fertil. Steril. 84, 218 (2005)PubMedCrossRef R.D. Dickerson, M.J. Putman, M.E. Black, K.R. Pinto, N.G. Diamond, S. Marynick, A.B. Pinto, Selective ovarian vein sampling to localize a Leydig cell tumor. Fertil. Steril. 84, 218 (2005)PubMedCrossRef
17.
go back to reference C.J. Petersons, M.G. Burt, The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours. Intern. Med. J. 41, 69–70 (2011)PubMedCrossRef C.J. Petersons, M.G. Burt, The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours. Intern. Med. J. 41, 69–70 (2011)PubMedCrossRef
18.
go back to reference G.A. Kaltsas, J.J. Mukherjee, B. Kola, A.M. Isidori, J.A. Hanson, J.E. Daie, R. Reznek, J.P. Monson, A.B. Grossman, Is ovarian and adrenal venous catheterization and sampling helpul in the investigation of hyperandrogenic women? Clin. Endocrinol. (Oxf). 59, 34–43 (2003)PubMedCrossRef G.A. Kaltsas, J.J. Mukherjee, B. Kola, A.M. Isidori, J.A. Hanson, J.E. Daie, R. Reznek, J.P. Monson, A.B. Grossman, Is ovarian and adrenal venous catheterization and sampling helpul in the investigation of hyperandrogenic women? Clin. Endocrinol. (Oxf). 59, 34–43 (2003)PubMedCrossRef
19.
go back to reference C. Regnier, A. Bennet, D. Malet, T. Guez, M. Plantavid, P. Rochaix, X. Monrozies, J.P. Louvet, P. Caron, Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma. J. Clin. Endocrinol. Metab. 87, 3074–3077 (2002)PubMedCrossRef C. Regnier, A. Bennet, D. Malet, T. Guez, M. Plantavid, P. Rochaix, X. Monrozies, J.P. Louvet, P. Caron, Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma. J. Clin. Endocrinol. Metab. 87, 3074–3077 (2002)PubMedCrossRef
20.
go back to reference V. Prassopoulos, F. Laspas, F. Vlachou, R. Efthimiadou, L. Gogou, J. Andreou, Leydig cell tumor of the ovary localised with positron emission tomography/computed tomography. Gynecol. Endocrinol. 27, 837–839 (2011)PubMedCrossRef V. Prassopoulos, F. Laspas, F. Vlachou, R. Efthimiadou, L. Gogou, J. Andreou, Leydig cell tumor of the ovary localised with positron emission tomography/computed tomography. Gynecol. Endocrinol. 27, 837–839 (2011)PubMedCrossRef
21.
go back to reference O.A. Sanz, P.R. Martinez, R.T. Guarch, M.J. Goñi, J.L. Alcazar, Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient. Maturitas 57, 214–216 (2007)PubMedCrossRef O.A. Sanz, P.R. Martinez, R.T. Guarch, M.J. Goñi, J.L. Alcazar, Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient. Maturitas 57, 214–216 (2007)PubMedCrossRef
22.
go back to reference T.A. Baramki, A.L. Leddy, J.D. Woodruff, Bilateral hilus cell tumors of the ovary. Obstet. Gynecol. 62, 128–131 (1983)PubMed T.A. Baramki, A.L. Leddy, J.D. Woodruff, Bilateral hilus cell tumors of the ovary. Obstet. Gynecol. 62, 128–131 (1983)PubMed
23.
go back to reference M. Marcelino, E. Nobre, J. Conceição, L. Lopes, H. Vilar, M. França Martin, A. Carvalho, S. André, A. Horta, J. De Castro, A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary. Acta Med. Port. 23, 113–118 (2010)PubMed M. Marcelino, E. Nobre, J. Conceição, L. Lopes, H. Vilar, M. França Martin, A. Carvalho, S. André, A. Horta, J. De Castro, A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary. Acta Med. Port. 23, 113–118 (2010)PubMed
24.
go back to reference J. Böhm, M. Röder-Weber, H. Höfler, M. Kolben, Bilateral stromal Leydig cell tumour of the ovary. Case report and literature review. Pathol. Res. Pract. 187, 348–352 (1991)PubMedCrossRef J. Böhm, M. Röder-Weber, H. Höfler, M. Kolben, Bilateral stromal Leydig cell tumour of the ovary. Case report and literature review. Pathol. Res. Pract. 187, 348–352 (1991)PubMedCrossRef
25.
go back to reference S. Duun, Bilateral virilizing hilus (Leydig) cell tumors of the ovary. Acta. Obstet. Gynecol. Scand. 73, 76–77 (1994)PubMedCrossRef S. Duun, Bilateral virilizing hilus (Leydig) cell tumors of the ovary. Acta. Obstet. Gynecol. Scand. 73, 76–77 (1994)PubMedCrossRef
Metadata
Title
“Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
Authors
Rosa Maria Paragliola
Francesco Torino
Paola Senes
Laura Castellino
Vanda Salutari
Alfredo Pontecorvi
Giovanni Scambia
Salvatore M. Corsello
Publication date
01-06-2014
Publisher
Springer US
Published in
Endocrine / Issue 2/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0066-0

Other articles of this Issue 2/2014

Endocrine 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.